adalimumab vs lisinopril

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of adalimumab and lisinopril. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
adalimumab TNF-Alpha Inhibitor (Biologic)
lisinopril ACE Inhibitor
Type
adalimumab Prescription
lisinopril Prescription
Summary
adalimumab

Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.

lisinopril

No summary available.

What It Treats
adalimumab

Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.

lisinopril

Information not available.

How It Works
adalimumab

Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.

lisinopril

Information not available.

Common Side Effects
adalimumab
  • Infections (like colds or sinus infections)
  • Injection site reactions (redness, itching, pain, or swelling)
  • Headache
  • Rash
lisinopril
  • Dizziness
  • Headache
  • Cough
  • Feeling tired
  • Diarrhea
FAERS Reports
adalimumab
  • Pain 49,062
  • Arthralgia 48,039
  • Injection Site Pain 47,251
  • Fatigue 39,111
  • Rheumatoid Arthritis 35,573
lisinopril
  • Fatigue 19,346
  • Nausea 17,996
  • Diarrhoea 16,771
  • Dyspnoea 13,650
  • Pain 13,303
Serious Warnings
adalimumab

Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.

lisinopril

No specific warnings noted.

Pregnancy
adalimumab

Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.

lisinopril

No pregnancy information available.

Also Compare, Nearby Drugs

How to Read This adalimumab vs lisinopril Comparison

adalimumab is classified in the TNF-Alpha Inhibitor (Biologic) drug class, while lisinopril sits within the ACE Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adalimumab has 219,036 submissions while lisinopril has 81,066. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adalimumab or lisinopril.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.